Update on trimetrexate, a folate antagonist with antineoplastic and antiprotozoal properties

Journal article

Peer reviewed

J T Lin and J R Bertino

Cancer investigation, Vol.9(2), pp.159-172

1991

PMID: 1830825

Abstract

Adult

Aged

Animals

Antineoplastic Agents - therapeutic use

Antiprotozoal Agents - therapeutic use

Clinical Trials as Topic

Drug Resistance

Female

Folic Acid Antagonists - therapeutic use

Humans

Male

Middle Aged

Neoplasms, Experimental - drug therapy

Quinazolines - pharmacology

Quinazolines - therapeutic use

Quinazolines - toxicity

Trimetrexate

10 Record Views

Title: Update on trimetrexate, a folate antagonist with antineoplastic and antiprotozoal properties
Creators: J T Lin - Program of Developmental Therapy and Clinical Investigation, Memorial Sloan-Kettering Cancer Center, New York, New York 10021
J R Bertino
Publication Details: Cancer investigation, Vol.9(2), pp.159-172
Date published: 1991
Grant note: CA-08010 / NCI NIH HHS
Academic Unit: Bertino Office
Language: English
Resource Type: Journal article
Identifiers: 991031666209604646